Levamisole: Clinical Trials

25 trials of Levamisole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 12 unknown, 1 recruiting. 14 Phase 3, 10 Phase 2, 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 314Unknown 7, Completed 6, Recruiting 1
Phase 210Completed 5, Unknown 5
Not applicable2Completed 1, Unknown 1
Phase 42Completed 1, Unknown 1

Follow Levamisole: new trials by email Literature Review of Levamisole trials Research Report on Levamisole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Levetiracetam (LEV) (60 mg/Kg) + 1 mg/kg Ketamine (KET), Levetiracetam (LEV) (60 mg/Kg) + 3 mg/kg Ketamine (KET), Levetiracetam (LEV) (60 mg/Kg) - Status Epilepticus
Phase 3RecruitingUniversity of Virginia7702026-03-062026-09-17
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20
The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children
Huaiqihuang granule, Prednisone, Levamisole placebo - Nephrotic Syndrome in Children
Phase 4UnknownJianhua Zhou4022023-04-262024-06-21
A Transdiagnostic Intervention for Health-related Habits (LEV)
Lev - Intervention, Life Style
Not applicableCompletedRegion Stockholm362023-01-252024-05-07
Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
LEV 1 mg/kg, LEV 1,5 mg/kg, LEV 2,5 mg/kg - Onchocerciasis, Ocular, Loiasis
Phase 2CompletedProgramme National de Lutte contre l'Onchocercose, Republic of the Congo2552021-01-162021-09-20
Pharmacological Modulation of Hippocampal Activity in Psychosis 2
Levetiracetam (LEV) 500 mg, Placebo - Schizophrenia; Psychosis
Phase 2CompletedVanderbilt University Medical Center622020-09-232024-02-05
Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
Levamisole, Isoprinosine, Levamisole and Isoprinosine - Coronavirus Disease (COVID-19)
Phase 3UnknownAin Shams University1002020-05-202020-05-05
Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
Levamisole and isoprinosine, Azithromycin and hydroxychloroquine - Respiratory Tract Infections
Phase 3UnknownCairo University602020-05-052020-05-13
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
Levamisole Pill + Budesonide+Formoterol inhaler, Lopinavir/Ritonavir + hydoxychloroquine - COVID-19
Phase 2 / Phase 3UnknownFasa University of Medical Sciences302020-04-042020-04-13
Novel Treatment of Advanced Hepatocellular Carcinoma
Anlotinib Hydrochloride Capsules, Arginine hydrochloride, levamisole - HCC
Phase 3UnknownThe First Affiliated Hospital of Zhengzhou University3002019-04-102019-05-15
Treatment of Advanced Intrahepatic Cholangiocarcinoma
Levamisole Hydrochloride, Anlotinib Hydrochloride Capsules - ICC
Phase 3UnknownThe First Affiliated Hospital of Zhengzhou University1522019-02-012019-05-07
Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole
levamisole hydrochloride, Androgens, Cyclosporins - Aplastic Anemia
Not applicableUnknownShengyun Lin2482018-01-012017-07-26
Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children
Levamisole Hydrochloride, Placebo - First Manifestation of Steroid Sensitive Nephrotic Syndrome
Phase 3CompletedAssistance Publique - Hôpitaux de Paris862017-09-062022-06-08
A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
rabbit ATG, Cyclosporine, Levamisole - Aplastic Anemia
Phase 2CompletedInstitute of Hematology & Blood Diseases Hospital, China402014-08-012026-02-11
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China502013-01-012013-01-03
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China1202012-07-012013-01-03
Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
levamisole, Prednisone - Anemia, Anemia, Hemolytic
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China1002012-04-012012-04-19
Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne
Levamisole - Acne
Phase 2 / Phase 3CompletedAhvaz Jundishapur University of Medical Sciences1692008-11-012011-05-05
Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
Levamisole, Placebo - Renal Dialysis
Phase 2CompletedShiraz University of Medical Sciences402008-03-012013-07-26
Efficacy Albendazole and Levamisole Against STH on Unguja
Albendazole, Levamisole - Ascariasis, Trichuriasis
Phase 4CompletedNatural History Museum, United Kingdom202006-06-012008-04-17

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Anemia, Aplastic (4)  ·  Colonic Neoplasms (4)  ·  Colorectal Neoplasms (4)  ·  Anemia (3)  ·  Anemia, Hemolytic (3)  ·  COVID-19 (3)  ·  Hematologic Diseases (3)  ·  Bone Marrow Failure Disorders (2)  ·  Hemoglobinuria (2)  ·  Hemoglobinuria, Paroxysmal (2)  ·  Loiasis (2)  ·  Nephrotic Syndrome (2)  ·  Proteinuria (2)  ·  Rectal Neoplasms (2)  ·  Thrombosis (2)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (4)  ·  Programme National de Lutte contre l'Onchocercose, Republic of the Congo (2)  ·  SWOG Cancer Research Network (2)  ·  The First Affiliated Hospital of Zhengzhou University (2)  ·  Ahvaz Jundishapur University of Medical Sciences (1)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Austrian Breast & Colorectal Cancer Study Group (1)  ·  Cairo University (1)  ·  European Institute of Oncology (1)  ·  Fasa University of Medical Sciences (1)  ·  Jianhua Zhou (1)  ·  NSABP Foundation Inc (1)  ·  Natural History Museum, United Kingdom (1)  ·  Region Stockholm (1)

Countries

China (8)  ·  United States (4)  ·  Iran (3)  ·  Canada (2)  ·  Republic of the Congo (2)  ·  South Africa (2)  ·  Austria (1)  ·  Egypt (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Sweden (1)  ·  Tanzania (1)

Top investigators

Robert J. Mayer, MD, FACP (2)  ·  Al B. Benson, MD, FACP (1)  ·  Anthony LA Fields, MD, FRCPC (1)  ·  Daniel G. Haller, MD (1)  ·  Elizabeth A. Poplin, MD (1)  ·  Francesco Tonelli, MD (1)  ·  Jaffer A. Ajani, MD (1)  ·  Jaideep Kapur, MD, PhD (1)  ·  Jianhua Zhou, Dr. (1)  ·  Joakim Lavesson, Bachelor (1)

Results publications

PMID 10550154, PMID 1090310, PMID 12622583, PMID 15774775, PMID 16877719, PMID 18720689, PMID 18775092, PMID 21997132, PMID 23547851, PMID 24341659, PMID 32738928, PMID 34651190, PMID 39513526, PMID 40615414, PMID 41525256

NIH funding

U10CA032102 (2), U10CA012027 (1)